Piramal Pharma's Stock Soars to New High, Outperforms Sector and Market
Piramal Pharma, a leading pharmaceutical company, saw a 5.12% increase in its stock price on November 1st, 2024, reaching a new 52-week and all-time high. The stock is currently rated as 'Hold' by MarketsMojo and has outperformed the sector by 4.21%. It has also shown consecutive gains for the last 5 days and is trading higher than its moving averages. In comparison to the overall market, Piramal Pharma has outperformed the Sensex by 4.84% in the last 1 day and 23.02% in the last 1 month, showcasing its strong performance and potential for growth in the pharmaceutical industry.
Piramal Pharma, a leading pharmaceutical company in the largecap industry, has seen a significant increase in its stock price on November 1st, 2024. The stock has gained 5.12%, closing at Rs. 284.35, which is also its new 52-week and all-time high.
According to MarketsMOJO, a leading stock market analysis and research platform, the stock of Piramal Pharma is currently rated as 'Hold'. This rating is based on the company's recent performance and market trends.
In today's trading session, Piramal Pharma has outperformed the sector by 4.21%, indicating a positive sentiment among investors. The stock has also shown a consecutive gain for the last 5 days, with a 15.1% increase in its returns during this period.
The stock has been highly volatile today, with an intraday volatility of 6.21%, calculated from the weighted average price. However, Piramal Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.
In comparison to the overall market performance, Piramal Pharma has outperformed the Sensex by 4.84% in the last 1 day and 23.02% in the last 1 month. This showcases the company's strong performance and potential for growth in the pharmaceutical industry.
Overall, Piramal Pharma's stock has shown a positive trend and has gained the attention of investors in the largecap industry. With its recent surge in stock price and strong performance, the company is poised for further growth in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
